Reuters logo
BRIEF-Asit Biotech announces grant from European Patent Office related to ASIT+ allergy immunotherapy product candidates​
November 23, 2017 / 6:35 AM / 20 days ago

BRIEF-Asit Biotech announces grant from European Patent Office related to ASIT+ allergy immunotherapy product candidates​

Nov 23 (Reuters) - ASIT BIOTECH SA:

* ‍EUROPEAN PATENT OFFICE GRANTS CO SECOND PATENT RELATED TO ACTIVE INGREDIENTS USED IN ASIT+™ ALLERGY IMMUNOTHERAPY PRODUCT CANDIDATES​

* ‍GRANT WILL BE EFFECTIVE FROM NOVEMBER 29, 2017 UNTIL JUNE 15, 2032 WITH A POSSIBLE EXTENSION OF 5 YEARS

* ‍PATENT PROSECUTIONS FOR GRANT IN CANADA, JAPAN, USA, CHINA, INDIA AND BRAZIL ARE ONGOING​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below